Travere Therapeutics restructures to boost financial health, expands the kidney therapy pipeline, and sees rapid growth for ...

While your local thrift shop could make your vintage dishware dreams come true, you want to pause for a second before ...

Numerous recalls have been initiated in 2025 due to the potential for damaged products, foodborne illness, contamination and undeclared food allergens.

Detailed price information for Ionis Pharmaceuticals (IONS-Q) from The Globe and Mail including charting and trades.

PureWow editors select every item that appears on this page, and some items may be gifted to us. Additionally, PureWow may ...

Q2 2025 Earnings Call Transcript August 7, 2025 Operator: Good day, and thank you for standing by. Welcome to the Arcutis ...

Biotech company Regeneron (NASDAQ:REGN) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3.6% ...

The funding push follows publication of a peer-reviewed clinical study showing that SentientLight's pulsed electromagnetic field (PEMF) therapy device achieved a 20% reduction in pain in knee ...

KEY HIGHLIGHTS First clinical site for Phase 2a clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with ...

An FDA expert panel has reignited a decades-old debate over hormone therapy treatment for menopause, as advocates argue over black box warnings and and a controversial 20th-century study.

The temporary suspension will allow the company to provide required information to the FDA to complete an Elevidys label update, which is expected to include a black box warning for acute liver injury ...

First patient dosed with CUE-102 for recurrent glioblastoma multiforme (rGBM) at Dana-Farber Cancer Institute (DFCI) BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clin ...